These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 6154062)

  • 1. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor content of nafoxidine treated experimentally induced canine prostatic hyperplasia.
    Trachtenberg J
    Clin Invest Med; 1985; 8(1):29-34. PubMed ID: 2580656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor content of the normal and hyperplastic canine prostate.
    Shain SA; Boesel RW
    J Clin Invest; 1978 Mar; 61(3):654-60. PubMed ID: 76635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of endocrine manipulations on the levels of cytosolic and nuclear receptors for androgens in dog prostate.
    Dube JY; Frenette G; Tremblay RR
    Invest Urol; 1981 May; 18(8):418-21. PubMed ID: 7228574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
    Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
    J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.
    Orgad U; Alroy J; Ucci A; Merk FB
    Lab Invest; 1984 Mar; 50(3):294-302. PubMed ID: 6199584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
    Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
    J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of prostatic hypertrophy in the dog with androstanediol.
    Walsh PC; Wilson JD
    J Clin Invest; 1976 Apr; 57(4):1093-7. PubMed ID: 59740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural and biochemical expressions of divergent differentiation in prostates of castrated dogs treated with estrogen and androgen.
    Merk FB; Ofner P; Kwan PW; Leav I; Vena RL
    Lab Invest; 1982 Nov; 47(5):437-50. PubMed ID: 6182388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.
    Moore RJ; Gazak JM; Wilson JD
    J Clin Invest; 1979 Mar; 63(3):351-7. PubMed ID: 219036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
    Pollack A; Irvin GL; Block NL; Lipton RM; Stover BJ; Claflin AJ
    Cancer Res; 1982 Jun; 42(6):2184-90. PubMed ID: 7074599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs.
    Winter ML; Liehr JG
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):211-9. PubMed ID: 8619228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate.
    Tunn UW; Schüring B; Senge T; Neumann F; Schweikert HU; Rohr HP
    Invest Urol; 1981 Jan; 18(4):289-92. PubMed ID: 6161104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
    Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
    Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
    Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
    J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hormone injections on levels of cytosolic receptors for estrogen, androgen and progesterone in dog prostate.
    Frenette G; Dube JY; Tremblay RR
    J Steroid Biochem; 1982 Sep; 17(3):271-6. PubMed ID: 6290786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.